Requirement for flow in the blockade of endothelium-derived hyperpolarizing factor (EDHF) by ascorbate in the bovine ciliary artery

British Journal of Pharmacology

Volumn 142, Issue 7, 2004, Pages 1081-1090

  Nelli, Silvia ^a   Dowell, Fiona J ^a   Wilson, William S ^a   Stirrat, Alison ^a   Martin, William ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Artery; Ascorbate; EDHF; Endothelium; Endothelium derived hyperpolarizing factor; Flow; Nitric oxide; Vasodilatation

Indexed keywords

ACETYLCHOLINE; APAMIN; ASCORBIC ACID; BRADYKININ; CHARYBDOTOXIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY BLOOD FLOW; ARTERY ENDOTHELIUM; ARTICLE; CATTLE; CILIARY ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; FLOW RATE; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; VASODILATATION;

ANIMALS; ASCORBIC ACID; BIOLOGICAL FACTORS; CATTLE; CILIARY ARTERIES; DOSE-RESPONSE RELATIONSHIP, DRUG; MUSCLE, SMOOTH, VASCULAR; MYOGRAPHY; REGIONAL BLOOD FLOW; VASODILATION;

EID: 4143106790     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705816     Document Type: Article

References (39)

1. BAUERSACHS, J., POPP, R., HECKER, M., SAUER, E., FLEMING, I. & BUSSE, R. (1996). Nitric oxide attenuates the release of endothelium-derived hyperpolarising factor. Circulation, 94, 3341-3347.
2. BOO, Y.C. & JO, H. (2003). Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases. Am. J. Physiol. Cell Physiol., 285, C499-C508.
3. BUSSE, R. & FLEMING, I. (2003). Regulation of endothelium-derived vasoactive autacoid production by hemodynamic forces. Trends Pharmacol Sci., 24, 24-29.
4. CAMPBELL, W.B. & HARDER, D.R. (2001). Prologue: EDHF - what is it? Am. J. Physiol., 280, H2413-H2416.
5. CARR, A.C., ZHU, B.Z. & FREI, B. (2000). Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ. Res., 87, 349-354.
6. DIMMELER, S., FLEMING, I., FISSLTHALER, B., HERMANN, C., BUSSE, R. & ZEIHER, A.M. (1999). Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature, 399, 601-605.
7. DING, Z., GODECKE, A. & SCHRADER, J. (2002). Contribution of cytochrome P450 metabolites to bradykinin-induced vasodilation in endothelial NO synthase deficient mouse hearts. Br. J. Pharmacol., 135, 631-638.
8. DOUGHTY, J.M., PLANE, F. & LANGTON, P.D. (1999). Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to the endothelium. Am. J. Physiol., 276, H1107-H1112.
9. DUDGEON, S., BENSON, D.P., MACKENZIE, A., PAISLEY-ZYSZKIEWICZ, K. & MARTIN, W. (1998). Recovery by ascorbate of impaired nitric oxide-dependent relaxation resulting from oxidant stress in rat aorta. Br. J. Pharmacol., 125, 782-786.
10. FONTANA, L., MCNEILL, K.L., RITTER, J.M. & CHOWIENCZYK, P.J. (1999). Effects of vitamin C and of a cell permeable superoxide dismutase mimetic on acute lipoprotein-induced endothelial dysfunction in rabbit aortic rings. Br. J. Pharmacol., 126, 730-734.
11. FRANKE, R., GRÄFE, M., SCHNITTLER, H., SEIIFGE, D., MITTERMAYER, C. & DRENCKHAHN, D. (1984). Induction of human vascular endothelial stress fibres by fluid shear stress. Nature, 307, 648-649.
12. FREI, B. (1994). Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am. J. Med., 97, 3A-15S.
13. GALLIS, B., CORTHALS, G.L., GOODLETT, D.R., UEBA, H., KIM, F., PRESNELL, S.R., FIGEYS, D., HARRISON. D.G., BERK, B.C., AEBERSOLD, R. & CORSON, M.A. (1999). Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002. J. Biol. Chem., 274, 30101-30108.
14. GO, Y.M., PARK, H.Y., MALAND, M.C, DARLEY-USMAR, V.M., STOYANOV, B., WETZKER, R. & JO, H.J. (1998). Phosphatidylinositol 3-kinase gamma mediates shear stress-dependent activation of JNK in endothelial cells. Am. J. Physiol., 44, H1898-H1904.
15. GRYGLEWSKI, R.J., PALMER, R.M.J. & MONCADA, S. (1986). Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature, 320, 454-456.
16. HONING, M.L.H., SMITS, P., MORRISON, P.J. & RABELINK, T.J. (2000). Bradykinin-induced vasodilatation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarization. Hypertension, 35, 1314-1318.
17. 2+ oscillations and STOC activation in endothelial cells. FASEB J., 12, 359-366.
18. KATZ, S.D. & KRUM, H. (2001). Acetylcholine-mediated vasodilatation in the forearm circulation of patients with heart failure: indirect evidence for the role of endothelium-derived hyperpolarizing factor. Am. J. Cardiol., 87, 1089-1092.
19. KEANEY, J.F. & VITA, J.A. (1995). Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor. Prog. Cardiovasc. Dis., 38, 129-154.
20. KILPATRICK, E.V. & COCKS, T.M. (1994). Evidence for differential roles of nitric oxide (NO) and hyperpolarisation in endothelium-dependent relaxation of pig isolated coronary artery. Br. J. Pharmacol., 112, 557-565.
21. LEVINE, G.N., FREI, B., KOULOURIS, S.N., GERHARD, M.D., KEANEY, J.F. & VITA, J.A. (1996). Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation, 93, 1107-1113.
22. MAY, J.M. (2000). How does ascorbic acid prevent endothelial dysfunction? Free Radic. Biol. Med., 28, 1421-1429.
23. MCCULLOCH, A.I., BOTTRILL, F.E., RANDALL, M.D. & HILEY, C.R. (1997). Characterisation and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed. Br. J. Pharmacol., 120, 1431-1438.
24. MCNEISH, A.J., NELLI, S., WILSON, W.S. & MARTIN, W. (2003b). Ascorbate inhibits EDHF in the bovine eye but not in the porcine coronary artery. In: EDHF 2002, ed. Vanhoutte, P.M., pp. 181-187. New York: Taylor & Francis.
25. MCNEISH, A.J., WILSON, W.S. & MARTIN, W. (2001). Dominant role of an endothelium-derived hyperpolarising factor (EDHF)-like vasodilator in the ciliary vascular bed of the bovine isolated perfused eye. Br. J. Pharmacol., 134, 912-920.
26. MCNEISH, A.J., WILSON, W.S. & MARTIN, W. (2002). Ascorbate blocks endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation in the bovine ciliary vascular bed and rat mesentery. Br. J. Pharmacol., 135, 1801-1809.
27. MCNEISH, A.J., NELLI, S., WILSON, W.S., DOWELL, F.J. & MARTIN, W. (2003a). Differential effects of ascorbate on endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation in the bovine ciliary vascular bed and coronary artery. Br. J. Pharmacol., 138, 1172-1180.
28. + channels. Circulation, 103, 1992-1998.
29. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43, 109-142.
30. NISHIKAWA, Y., STEPP, D.W. & CHILIAN, W.M. (1999). In vivo location and mechanism of EDHF-mediated vasodilatation in canine coronary circulation. Am. J. Physiol., 277, H1252-H1259.
31. NISHIKAWA, Y., STEPP, D.W. & CHILIAN, W.M. (2000). Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilatation in vivo. Am. J. Physiol., 279, H459-H465.
32. REES, D.D., PALMER, R.M.J., SCHULZ, R., HODSON, H.F. & MONCADA, S. (1990). Characterisation of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol., 101, 746-752.
33. REMUZZI, A., DEWEY JR, F. & GIMBRONE JR, M.A. (1984). Orientation of endothelial cells in shear fields in vitro. Biorheology, 21, 617-630.
34. RUBANYI, G.M. & VANHOUTTE, P.M. (1986). Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am. J. Physiol., 250, H822-H827.
35. WALDRON, G.J., DING, H., LOVREN, F., KUBES, P. & TRIGGLE, C.R. (1999). Acetylcholine-induced relaxation of peripheral arteries isolated from mice lacking endothelial nitric oxide synthase. Br. J. Pharmacol., 128, 653-658.
36. WALDRON, G.J. & GARLAND, C.J. (1994). Effect of potassium channel blockers on L-NAME insensitive relaxations in rat small mesenteric artey. Can. J. Physiol. Pharmacol., 72, 11.
37. WASSERMAN, S.M., MEHRABAN, F., KOMUVES, L.G., YANG, R.B., TOMLINSON, J.E., ZHANG, Y., SPRIGGS, F. & TOPPER, J.N. (2002). Gene expression profile of human endothelial cells exposed to sustained fluid shear stress. Physiol. Genomics, 12, 13-23.
38. WELSH, D.G. & SEGAL, S.S. (2000). Role of EDHF in conduction of vasodilatation along hamster cheek pouch arterioles in vivo. Am. J. Physiol., 278, H1832-H1839.
39. ZYGMUNT, P.M. & HÖGESTÄTT, E.D. (1996). Role of potassium channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery. Br. J. Pharmacol., 117, 1600-1606.